This trial is designed to evaluate the use of cells from the patient’s own fat for the treatment of Spinal Cord Injury. The trial is being conducted by Korea University Anam Hospital in Seoul, in conjunction with RNL Bio Company Ltd. Participants will receive different doses of mesenchymal stem cells from their own fat injected directly into their veins (intraveneous injection). Participants will be monitored for complications, as well as changes in their clinical condition. The trial and expects to enrol 15 subjects by April 2014.